AVF American International Group JR Sub Deb Ser A-5

Notice is hereby given that Stull, Stull & Brody filed a lawsuit on October 27, 2008 in the United States District Court for the Southern District of New York seeking class action status on behalf of purchasers of 7.70% Series A5 Junior Subordinated Debentures (NYSE: AVF) of American International Group, Inc. ("AIG" or the "Company") pursuant and/or traceable to the Company's public offering on December 11, 2007 (the "Offering").

If you purchased or acquired AIG 7.70% Series A5 Junior Subordinated Debentures pursuant and/or traceable to the Offering, you may apply to the Court to serve as lead plaintiff in the action no later than December 9, 2008.

The Complaint asserts claims pursuant to Sections 11, 12(a)(2) and 15 of the Securities Act of 1933 (the "Securities Act"), 15 U.S.C. Sections 77k, 77l and 77o against certain officers and directors of AIG and certain Underwriters of the Offering. The Underwriters include Citigroup Global Markets Inc. (NYSE: C), Merrill Lynch & Co., Inc. (NYSE: MER), Morgan Stanley & Co. Inc. (NYSE: MS), UBS Securities LLC (NYSE: UBS), Wachovia Capital Markets, LLC (NYSE: WB), Bank of America Securities LLC (NYSE: BAC), Bear, Stearns & Co. Inc., The Bear Stearns Companies, LLC, RBC Capital Markets and Wells Fargo Securities (NYSE: WFC).

The Complaint asserts that AIG's Prospectus issued in connection with the Offering contained material misstatements and omissions, which Plaintiffs and the proposed Class relied upon to their detriment. The representations made in the Company's Prospectus were materially false and misleading because at the time of the Offering AIG was already suffering from several adverse factors that were not revealed and/or adequately addressed in the Prospectus. These factors include, but are not limited to, the fact that, contrary to the representations contained in the Prospectus: (i) AIG did not have a relatively small exposure to loss associated with credit swaps sold by certain variable interest entities; (ii) AIG's exposure to loss associated with credit protection assumed by AIG Financial Products Corp. and AIG trading Croup Inc., including their respective subsidiaries ("AIGFP") on portfolios of loans or debt securities was not remote, even in severe recessionary market scenarios; and (iii) AIG's financial statements and financial information, as contained in and incorporated by reference into the Prospectus, were not presented in conformity with generally accepted accounting principles ("GAAP").

A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class members claim is typical of the claims of other class members, and that the class member will adequately represent the class. Under certain circumstances, one or more class members may together serve as "lead plaintiff." Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. You may retain Stull, Stull & Brody, or other counsel of your choice, to serve as your counsel in this action. Stull, Stull & Brody has litigated many class actions for violations of securities laws in federal courts over the past 30 years and has obtained court approval of substantial settlements on numerous occasions. Stull, Stull & Brody maintains offices in New York and Los Angeles.

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Howard Longman, Esq. at Stull, Stull & Brody by e-mail at TSVI@aol.com, or Tzivia Brody, Esq. at SSBNY@aol.com, or by calling toll-free 1-800-337-4983, or by fax to 1-212-490-2022, or by writing to Stull, Stull & Brody, 6 East 45th Street, New York, NY 10017. You can also visit our website at www.ssbny.com.

Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.

Contact: Howard Longman, Esq. Email Contact Tzivia Brody, Esq. Email Contact 1-800-337-4983 fax: 1-212-490-2022 www.ssbny.com